A scaled-down model for the translation of bacteriophage culture to manufacturing scale by Junaid Ali (7125998) et al.
A scaled down model for the translation of bacteriophage culture to manufacturing scale 
Junaid Ali1*, Qasim Rafiq2 and Elizabeth Ratcliffe1  
1Centre for Biological Engineering, Department of Chemical Engineering, Loughborough University, 
Loughborough, Leicestershire, LE11 3TU 
2Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University 
College London, London, WC1E 6BT, UK 
*Correspondence: J.Ali@lboro.ac.uk 
Abstract 
Therapeutic bacteriophages are emerging as a potential alternative to antibiotics and synergistic 
treatment for antimicrobial resistant infections. This is reflected by their use in an increasing number 
of recent clinical trials. Many more therapeutic bacteriophage are being investigated in pre-clinical 
research and due to the bespoke nature of these products with respect to their limited infection 
spectrum, translation to the clinic requires combined understanding of the biology underpinning the 
bioprocess and how this can be optimised and streamlined for efficient methods of scalable 
manufacture. Bacteriophage research is currently limited to laboratory scale studies ranging from 1-
20mL, emerging therapies include bacteriophage cocktails to increase the spectrum of infectivity and 
require multiple large scale bioreactors (up to 50L) containing different bacteriophage – bacterial host 
reactions. Scaling bioprocesses from the millilitre scale to multi litre large scale bioreactors is 
challenging in itself, but performing this for individual phage-host bioprocesses to facilitate reliable 
and robust manufacture of phage cocktails increases the complexity. This study used a full factorial 
Design of Experiments (DoE) approach to explore key process input variables (temperature, time of 
infection, multiplicity of infection, agitation) for their influence on key process outputs (bacteriophage 
yield, infection kinetics) for two bacteriophage – bacterial host bioprocesses (T4 – E. coli; Phage K – 
S. aureus). The research aimed to determine common input variables that positively influence output 
yield and found that the temperature at the point of infection had the greatest influence on 
bacteriophage yield for both bioprocesses. The study also aimed to develop a scaled down shake flask 
model to enable rapid optimisation of bacteriophage batch bioprocessing and translate the bioprocess 
into a scale up model with a 3L working volume in stirred tank bioreactors. The optimisation 
performed in the shake flask model achieved 550-fold increase in bacteriophage yield and these 
improvements successfully translated to the large scale cultures. 
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Introduction 
Antimicrobial resistance is increasing at an alarming rate with few treatment options for 
related diseases and a dearth of novel solutions (Davies et al, 2013). The nature of resistance is highly 
complex with a multitude of factors that each contributes to resistant organisms forming. 
Antimicrobial resistant bacteria can develop because of self-inflicting factors such as patients not 
completing a course of antibiotics or saving and sharing antibiotics amongst others (Goldsworthy et 
al, 2009). Exposure to antibiotics, when their use will bring no additional benefit may also allow the 
formation of resistant cells (McNulty et al, 2007). Additionally, transfer of genetic material between 
bacteria which codes for resistance genes plays a major role in the development of resistant bacteria 
(Burmeister, 2015). It is estimated that mortality rates will rise to over 10 million per annum by 2050 
due to infections caused by resistant bacteria and therefore, novel strategies are needed to tackle 
antimicrobial resistance (AMR). Additionally, it is predicted that AMR will impact global GDP by 
over $100 trillion by 2050 (O’Neill, 2014). Studies have shown that approximately 54% of 
predominant E. coli strains are resistant to at least one antimicrobial drug (Tadesse et al, 2012). More 
recently, a study was carried out where 137 Escherichia coli (E. coli) clinical isolates were tested for 
resistance to 11 commonly used antibiotics and showed 50 of the isolates tested were resistant to 10 of 
the 11 antibiotics, highlighting the urgent requirement for alternative therapies (Olorunmola et al., 
2013).  More recently, a study sampled 862 clinical isolates of E. coli from a variety of animals 
including chickens, pigs and cows and found that 94% of strains were resistant to 1 drug and 83% 
were resistant to 3 antimicrobial classes (Yassin et al, 2017).  
At the beginning of the 20th century, bacteriophages (phages) were believed to have the 
potential to act as antimicrobial agents, although it is only within the past two decades that their true 
potential has emerged (Mandal et al, 2014). Bacteriophages are the most abundant organisms in the 
biosphere with an estimated 1 x 1029 phages on Earth. They can be easily isolated from rivers and 
sewers and cultured through infecting their host strain, and then purified via centrifugation and simple 
filtration (Millard et al, 2011). Phages initially showed potential in treating bacterial infections in the 
early 20th century, however, with the discovery of penicillin in 1928 and the advent of the antibiotic 
age, phage therapy research did not progress due to the lack of medical need. Although early trials 
using phages against pneumococci and Corynebacterium diphtheria showed promise in the 1920-
1930s, poorly controlled trials and inconsistencies within results led to discontinuation of phage 
therapy clinical trials (Whittebole et al, 2014, Pires et al, 2016). By the 1940s, Western medical 
regulations dampened enthusiasm on phage therapy despite research remaining high in the former 
USSR. Between 1940-1950 there were around 2,000 studies published on phage therapy, compared to 
the near 20,000 studies using penicillin. In Eastern European countries, bacteriophage therapy is a tool 
used within modern medicine despite several major concerns regarding their safety (Nale et al, 2016). 
Some of the safety concerns have arisen because the production of phage requires infection and lysis 
of host bacteria which leads to the release of bacterial endotoxins. These endotoxins must be removed 
from the final culture before clinical use. During the lysis of the host cell, the bacterium releases 
newly formed phages and bacterial endotoxins, which must be removed from final product 
preparation due to their inflammatory properties that can cause organ damage, failure and sepsis. 
Although phage preparations can be purified from endotoxins to the levels required for regulatory 
approved clinical trials, the purification process is long and expensive and represents one of the main 
hurdles to success (Slofstra et al, 2006, Catalão et al, 2013, Georgel, 2016). Aside from safety, other 
disadvantages of phage therapy include their narrow host range which can limit their treatment 
potential and their poor distribution as they have no mechanism for movement and rely on random 
interactions (Loc-carillo & Abedon, 2011). However over the past two decades Western medicine has 
regained interest in bacteriophage therapy with 35 carefully regulated clinical trials since 1995, 22 of 
which occurred in the past 10 years (clinicaltrials.gov). To date, there have been 5 clinical trials using 
phage against E. coli and 6 against Staphylococcus aureus (S. aureus). Additionally, a PubMed recent 
literature search showed >1,000 journal articles were published in 2017 when searching for the 
combined terms “bacteriophage” and “therapy” (PubMed 2018, 2018). 
 With renewed interest and increasing levels of current research, phage therapies are emerging 
as potential tools against antimicrobial resistant infections (Bragg et al, 2014, Speck & Smithyman 
2016, Lin et al, 2017). However in addition to the required improvements in phage purification, the 
standardisation and phage production process has not been widely explored. Throughout the literature 
there are references to the importance as well as the need for scale up, yet studies exploring large 
scale manufacture of phages are scarce (Warner, et al, 2014, lomtscher et al, 2017, Krysiak-Baltan et 
al, 2018). For successful translation of phage therapies into the clinic, scalable, robust and cost 
effective manufacturing processes are required to match the expected increased demand. This 
necessitates the identification of key process input variables (KPIV) and key process output variables 
(KPOV) such that optimisation strategies can be employed for improved bioprocess outputs, as well 
as for standardisation of common units of manufacture. Additionally, understanding the range of the 
KPIV used allows greater control over the final product (Ratcliffe et al, 2011). 
The aim of this study was to determine common KPIV that could positively influence 
bacteriophage output yield and elucidate combined conditions at which the greatest phage yield could 
be achieved for two different bacteriophage bioprocesses (T4 – E. coli; Phage K – S. aureus). These 
organisms were chosen as suitable candidates given the previous use of T4 phage and the worrying 
rise in S. aureus infections (Sarker et al,2012). Using a full factorial Design of Experiments (DoE) 
approach a further research aim was to characterise the design space for each bioprocess in a scaled 
down shake flask model for high throughput analysis with validation of the result to ensure reliability 
before translating to large scale culture. The study focussed on developing the approach for scalable 
batch bioprocessing which is currently employed in manufacture of phage for clinical trials with a 
view towards developing the research towards continuous bioprocessing in future studies.  
 Using a full factorial design allows a methodological approach to enable parallel analysis of 
multiple experimental factors whilst gaining insight into interactions between each factor and an 
estimation of the effects of each of the variables such as the contour plots seen in Figure 1 described 
and discussed below. Recently, Stuible et al 2018 showed the effectiveness of using DoE for high 
bacterial cell density for protein production. By examining their KPIV they determined the levels at 
which greatest protein and antibody production could be achieved. A further advantage of the full 
factorial approach in characterising a bioprocess design space is the ability to predict other areas 
where similar levels can be produced, which can be a powerful tool when increasing achievable scale.  
KPIV investigated in the scaled down model were temperature, multiplicity of infection 
(MOI), agitation, and time of infection due to the potential impact they may have on the culture. They 
were used to determine levels of the input variables in combination that could significantly impact 
upon key process output variables based on output phage titre and measures of bioprocess yield 
(outputs vs. inputs). The temperature of infection has not been widely studied to date with minimal 
studies examining its effect on phage titre. Greico et al, (2012) showed that a reduction in temperature 
can improve the phage titre achieved, whilst Bleckwenn et al 2005 hypothesised that a reduction in 
temperature aids viral protein synthesis. Due to the phage infection mechanism, reducing the 
temperature may aid in the integration of phage DNA leading to an improvement in the production of 
phage and allow it to become more efficient thereby producing higher titres. MOI was investigated as 
a high MOI may cause negative feedback whilst using an MOI that was too low may increase the time 
for phage propagation (Bourdin et al, 2014, Heggen et al, 2014, Bryan et al, 2016, Alves et al, 2014, 
O’Flaherty et al 2005). Agitation was also investigated as mixing of the culture is vital for 
homogeneity of oxygen and pH in the culture to allow optimal growth of host cells (Bourdin et al 
2014, Greico et al, 2012, Basdew et al 2012, Paul et al 2011). Finally, the time of infection was 
investigated, as although not previously studied, being able to decrease the time would have a 
significant impact on bioprocessing efficiency. Moreover, by allowing phage infection to take place 
over a longer period, there is a risk that phage may bind to receptors on lysed host cells and therefore 
be lost during the filtration steps (Alves et al, 3024, Estrella et al, 2016, Choi et al, 2010).  
Materials and methods 
Bacterial and phage strains 
E. coli B and T4 bacteriophage were purchased from the University of Reading. S. aureus 
(19685) and bacteriophage K (19685-B1) were purchased from ATCC. 
Media and growth conditions 
Unless otherwise stated, all reagents were purchased from Sigma-Aldrich, Irvine, UK. Luria 
broth (LB) (miller) medium was used for growth of E. coli and T4 phage. E. coli was grown at 37oC 
with constant agitation at 225rpm in a shaking incubator (Midi shaking incubator SQ-4020, Wolflabs, 
York, United Kingdom), whilst phage infection took place at its indicated temperature. S. aureus was 
grown at 37oC with constant agitation at 150rpm. All scaled down experiments were conducted in 
shake flasks using a 20ml volume. For long term storage, bacterial cultures were stored in a 20% 
glycerol solution at -80oC (Bonilla et al, 2016). Phage were stored at 4oC but for long term storage, 
phage were stored in a 50% glycerol solution at -80oC (Fortier, L. & Moineau 2009). S. aureus was 
grown in brain heart infusion (BHI) media and infected with phage K. For all experiments, E. coli was 
grown using LB media or LB agar. S. aureus was grown using BHI media or BHI agar. 0.6% LB agar 
was used for T4 plaque assays, made from 2g tryptone, 1g yeast, 1.2g bacteriological agar 
(Thermofisher, Baskingstoke, UK), 2g NaCl per 200ml (Rustad et al, 2018). 0.7% BHI agar was used 
for phage K plaque assays, made from 7g BHI media, 1.4g bacteriological agar (Thermofisher, 
Baskingstoke, UK) per 200ml (O’Flaherty et al, 2005). Pre-culture of host cells was conducted at 
37oC whilst phage infection took place at the indicated temperature. 
Propagation, purification with centrifugation and concentration of phage 
A single colony of each bacterium from agar plate culture was inoculated in 20ml media and 
cultured at the respective conditions overnight. Following this, a dilution of the culture was made to 
reach an optical density (OD600nm) of 0.05 using a Shimadzu biospec mini spectrophotometer. The 
culture was grown at 37oC with agitation at 150rpm (S. aureus) or 225rpm (E. coli) shaking until it 
reached an (OD600nm) of 0.25 and infected with phage. At the point of harvest, the culture was 
centrifuged at 4,600g for 10 minutes and filtered using a 0.22μm filter (Millipore, Watford, UK). 
Phage were concentrated using a 20% PEG-8000 solution overnight at 4oC. The phage were 
centrifuged for 1 hour at 4,600g and the supernatant decanted. The pellet was resuspended and stored 
in LB media for T4 phage or BHI media for phage K.  
Enumeration of phage 
All experiments were enumerated using the plaque assay. An overnight culture of host 
bacteria, from a single colony no more than 24 hours old on the respective agar plates, was agitated at 
225rpm (E. coli) or 150rpm (S. aureus) at 37oC was centrifuged at 4,600g for 10 minutes and re-
suspended in 3ml fresh media (O’Flaherty et al, 2005). The 3ml culture was added to either 5ml 0.6% 
LB bacteriological agar or 0.7% BHI bacteriological agar for E. coli and S. aureus respectively 
(Bonilla et al, 2016). The mixture was poured onto fresh LB or BHI agar plate. Appropriate dilutions 
of the phage were spotted onto the top agar at appropriate serial dilutions. The number of cells at the 
point of infection, OD600nm 0.25, was used to calculate the phage per input cell whilst the MOI was 
taken into account to determine the phage output per input phage. Titres achieved are from the 
purified precipitated post PEG/NaCL purification using a single step purification. 
Design of Experiment design 
The full factorial experiment was designed using Minitab16. A 4 factor, 3 level design was 
created equating to 81 experiments for both phage bioprocess design spaces. Table 1 shows the 
parameters and levels used for each bioprocess. Baseline (or Control) conditions for T4 phage were as 
follows; MOI 2.5, 225rpm, 3 hours infection, 37oC whilst baseline (control) conditions for phage K 
were; MOI 1, 8 hours, 150rpm, 37oC, determined from literature review (refer to supplementary data). 
The baseline acts as a reference point to currently used levels within the literature and acts as a control 
for changes to the bioprocess to be assessed. Baseline conditions are highlighted in bold. Each of the 
varying conditions were run as singular experiments to build the streamlined design space, with 
enumeration by duplicate plaque assays.  
Table 1. A table to show the KPIV and levels used to characterise the bioprocess design space for T4 
and phage K in the shake flask model. Baseline (control) conditions shown in emboldened text. 
 
 
 
 
 
Adsorption analysis 
 All experiments were performed in quadruplicate with each experiment enumerated with 
duplicate plaque assays. Sacrificial shake flasks were setup with an overnight host culture diluted to 
0.05 OD600nm and grown to 0.25 OD600nm. Upon infection of the culture, shake flasks were taken out of 
the incubator at staggered times every 30s and a 1ml sample was filtered with a 0.22μm filter. The 
sample was then enumerated as described above. 
Bioreactor experimentation 
A 5L Biostat B Plus stirred-tank bioreactor (Sartorius, Göttingen, Germany) was used with a 
3L working volume, with the greatest titre conditions determined from baseline and small scale 
factorial experiments of the shake flask model, additional parameters in the bioreactor were dO2, 
maintained at 100%, pH maintained at 7.0 and an impellor used for agitation 150rpm (S. aureus) and 
225rpm (E. coli). A single colony of host culture was inoculated in a 1% working volume and grown 
overnight in a shake flask 37oC. E. coli cultures were agitated at 225rpm and S. aureus cultures were 
agitated at 150rpm. The volume was inoculated into the bioreactor and grown to 0.25 OD600nm. The 
culture was then infected and allowed to grow according to baseline or greatest titre conditions as 
Key Process Input Variable (KPIV) T4 Level Phage K Level 
Agitation (RPM) 100, 225, 400 100, 150, 200 
MOI 1, 2.5, 10 0.1, 1, 10 
Temperature (oC) 20, 28, 37 20, 28, 37 
Time of infection (hours) 1, 3, 6 4, 8, 16 
determined by shake flask model. Each experiment was completed in triplicate with each experiment 
enumerated with triplicate plaque assays. 
Statistical tests 
 All statistical analyses were performed using IBM SPSS 23. They included paired two sample 
t-test and two-way analysis of variance (ANOVA). A p value of <0.05 was considered to be 
statistically significant. 
 
Results and Discussion 
Scaled down optimisation model 
The study aimed to improve the batch bioprocess for T4 phage and phage K using a DoE 
approach. Phage acting against E. coli was considered an ideal candidate as it has previously been 
used in humans who took oral doses to act against E. coli K803; whilst Sarker et al (2012) applied it 
to determine how faecal E. coli K12 and WG5 counts were affected with no adverse effect noted on 
the subjects in either study (Bruttin and Brussow, 2005, Denou et al, 2009). To ensure the scaled 
down model and methodology could be developed as an appropriate research tool for use with 
different phage bioprocesses, it was important to use two exemplar phage bioprocesses with different 
bacterial hosts; phage K acting against S. aureus was chosen due to S. aureus also being a target of 
multiple phage clinical trials because of its antimicrobial resistance threat.  
A full 4 factor 3 level DoE design generated 81 runs. The contour plots illustrated Figure 1 
show the design space with the zone of greatest output phage titre conditions across the whole 
experiment shown in the centre of the experiment design (darker green zones indicate higher phage 
titre). No statistically significant differences were found between titres achieved within each level 
used for each input variable. The contour plots are therefore useful to show differences in phage titre 
under combined input variable influence and to check whether the experiment design is appropriate. 
The design is appropriate as all zones are central within the contour plots, if the zones were not central 
and were against the edge of the graph this would suggest that a shift in experimental design was 
required.  
  
 
 
 
 
 
 
 
Figure 1. Contour plot analysis of the Scaled down model for T4 and phage K. Contour plots 
indicating the zones of greatest output phage titre (pfu/ml) for T4 and phage K. T4 graphs A-C, Phage 
K graphs D-G with respective phage titres in plaque forming units per ml (pfu/ml): (A) Time of 
infection (hours, h) vs agitation during infection (Revolutions per minute, RPM); (B)  Time of 
infection vs temperature of infection (oC); (C) agitation during infection (RPM) vs temperature of 
infection (oC); (D) temperature of infection vs time of infection; (E) Multiplicity of Infection (MOI) 
vs time of infection; (F) agitation during infection vs time of infection; (G) temperature of infection 
vs agitation during infection.  
 
Although no distinct peaks were shown for T4 phage, the contour plots (Figure 1, A-C), 
showed windows of operation for each parameter where elevated phage titres were achieved. The 
darker areas within the contour plot (Figure 1) represent conditions where elevated titres, >5 x 1011 
pfu/ml, can be achieved. However, due to a lack of statistical significance between each levels of the 
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conditions used, a wide range of levels have been estimated to achieve the elevated titres i.e a distinct 
peak of optimal input parameters.  
A T4 phage titre of >1x 1013 pfu/ml was achieved using  an MOI of 2.5, 225rpm agitation 
during infection, 28oC infection temperature and 3 hours infection time. The T4 baseline process used 
conditions that are commonly found within the literature, to act as a control. Whilst current T4 
processes commonly use a range of MOIs, agitation and times of infection, 2.5, 225rpm and 3 hours 
was chose to give an overall representitive respectively. However, the greatest difference between 
currently used conditions and the conditions presented here was the temperature of infection, 37oC, 
which achieved an output  phage titre of 4.2 x 1010 pfu/ml. The greatest output T4 titre was actually 
2.2 x1013 pfu/ml with slightly different infection temperature conditions of 28oC which gave around a  
500-fold higher titre than at 37 oC  i.e the baseline process which is comparable to the literature 
(p<0.0001, paired t-test) (4.5 x 1010 pfu/ml). There is variation in the literature on achievable levels 
but this represents greater than 10-fold increase above the highest achievable current levels 
(Sauvageau & cooper 2010, Bourdin et al, 2014, Bonilla et al, 2016). 
The greatest phage K titre achieved was 6x1012 pfu/ml using an MOI of 1, 150rpm agitation 
during infection, 8 hours infection time at 28oC temperature, only differing from the phage K baseline 
(control) conditions in temperature and generating a statistically significant improvement in phage 
titre (5 x 1010 pfu/ml) (p=0.0004, paired t-test). Although this was the greatest output titre, a lower 
MOI of 0.1, 150rpm agitation during infection, and a lower infection time of 4 hours at 28oC achieved 
near identical titres (3.5 x 1012 pfu/ml). These conditions were taken forward into further experiments 
as this output titre was achieved using a lower level of input phage stock and a shorter infection time 
of 4 hours (compared to 8 hours). As far as the authors are aware this is the first study to determine 
conditions to maximise phage K titre.  
 
 
 
Interaction analysis 
The interaction effects plot (Figure 2) shows the mean response for all possible combinations 
of each input variable and level investigated (described as low, mid or high) for the T4 phage and 
phage K experiments. Parallel lines within each box indicate no interaction between levels used, 
however, non-parallel lines that cross indicate statistically significant interactions (p<0.05). 
Statistically significant interactions were confirmed using a two way ANOVA. The graph shows that 
28oC, MOI 2.5, 225rpm, and 3 hours gave the greatest T4 phage titre whilst 28oC, MOI 0.1, 150rpm 
and 8 hours gave the greatest phage K titre.  
 
 
.  
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Figure 2. Interaction Effects Plot. The interaction plot shows the mean response for all 
combinations of input variables and levels investigated for the T4 and phage K scaled down shake 
flask model. The top plot shows results for T4 and the bottom plot shows results for phage K, within 
each plot the graphs are numbered showing which input variables are combined as follows: 1 
Multiplicity of Infection (MOI) vs. Temperature; 2 Agitation vs. MOI; 3 Time vs. Temperature; 4 
Temperature vs. MOI; 5 Agitation vs. MOI; 6 Time vs. MOI; 7 Temperature vs. Agitation; 8 MOI vs. 
Agitation; 9 Time vs. Agitation; 10 Temperature vs. Time; 11 MOI vs. Time; and 12 Agitation vs. 
Time. Parallel lines indicate no significant interaction, non-parallel lines that cross indicate 
statistically significant interactions (p<0.05, two-way ANOVA). 
  
T4 interaction analysis:    
Temperature: Figure 2a demonstrates that the midpoint for the temperature of infection (28oC) gives 
the greatest titre against each of the mid-point levels used for MOI, agitation and time of infection 
(figure 2a box 1-3). Moreover, against the majority of the high and low levels for the MOI, agitation 
and time of infection, 28oC gave a greater mean average T4 titre compared to 20oC and 37oC e.g 
figure 2a graph 1 and 3 at MOI 1, 10 and 6 hours respectively. However, there were some instances 
where 28oC did not give the greatest titre. Figure 2a graph 3, shows the greatest mean titre after 1 hour 
infection is achieved at 37oC.This may be because a higher infection temperature will favour E. coli 
host growth allowing for a low infection time as the host will replicate faster at 37oC than at 28oC or 
20oC, potentially increasing the number of host cells available for phage infection.  
MOI: At 20oC, graph 4 shows an MOI 1 gave the greatest average mean titre. At a low temperature of 
infection, it may be more beneficial to the titre to use a lower MOI to prevent the host from being 
infected by more phage i.e a higher MOI will see more host cells infected and if they are unable to 
replicate due to a low temperature, the overall titre may be reduced. Statistically significant 
interactions were seen between 28oC and 20oC, p=0.019 although there was no significant difference 
between 37oC and 28oC or 20oC despite the average titre being 3.01e11, 1.59e11 and 1.12e11pfu/ml 
respectively. Statistically significant interactions were seen between at an MOI 1 between 20-28oC 
and an MOI 10 20-28oC and 20-37oC p=0.01, p=0.001 and p=0.001 respectively. The interaction plot 
shows the influence of temperature of infection on T4 titre irrespective of the MOI or time of 
infection. 
Agitation:  The agitation appeared to have the lowest effect on T4 titre. Graphs 7, 8 and 9, Figure 2a, 
show the mid-point (225rpm) as giving the greatest titre at each mid-point value, however, at the low 
and high levels, this was not always consistent. Graph 8, Figure 2a, shows that the greatest titre was 
achieved at 100rpm, MOI 10. Using a lower agitation may prevent optimal mixing within the culture 
and therefore the phage may not be able to bind to the host and propagate as efficiently as possible. 
Using a higher MOI may allow more phage to infect the host thus enabling and improving the 
propagation. 
Time: Figure 2a, graph 11 shows a weak interaction between the low and high input variable values 
i.e near parallel lines, but strong interactions between the mid-point value. This graph shows a weak 
interaction between each MOI at the low and high infection time (1 and 6 hours respectively) but a 
strong interaction shown at the midpoint time (3 hours) with all MOIs investigated. Therefore, MOI at 
the high and low levels has a weak effect on the titre. This trend is also seen in graphs 10 and 12.  
Phage K interaction analysis: 
Temperature: In addition to the T4 interaction plot, the phage K interaction plot also showed that the 
temperature of infection played an interesting role on the final phage titre. Figure 2b, graphs 1, 2 and 
3 show that 28oC gave the greatest titre at the high and low levels for all factors investigated. 
Statistically significant differences were found in the average mean titre between 20-28oC, 20-37 oC 
and 28-37oC p=0.003, p=0.02 and p=0.014 respectively. Together, this plot adds weight to the 
argument that a reduced temperature of infection allows for a higher phage titre to be achieved and 
backs up the results in the contour plot in Figure 1 whilst showing it is the most important factor in 
phage K propagation.   
MOI: Compared to Figure 2a for T4, Figure 2b, graphs 4, 5 and 6 shows far more variance in the MOI 
and its effect on titre. Graph 5 shows at each of the agitation rates, a different MOI gave the greatest 
titre. Therefore, this shows that the MOI has little effect on the titre but is worthwhile noting as using 
a lower MOI will improve efficiency of a bioprocess. Statistically significant interactions were 
observed at MOI 0.1, 20-37oC, p=0.008 and at 4 hours infection 20-37oC p=0.002.  
Agitation: Interestingly, Figure 2b, graphs 7, 8 and 9 show that 150rpm gave the greatest titre at each 
of the levels used for all conditions. Moreover, 28oC also gave the greatest phage K titre and therefore 
the interaction analysis shows that the temperature and agitation of infection play the greatest role in 
phage K propagation. Statistically significant interactions were seen at 100rpm between MOI 0.1-1 
and 1-10 p=0.02 and p=0.003 respectively, graph 8. 
Time: Similarly to the MOI, the time of infection was shown to be variable with different times of 
infection giving the greatest titre at the different levels and conditions used. However, at the mid-point 
of each condition, 8 hours infection always gave the greatest titre, figure 2b graphs 10-12. Given the 
parallel lines between 4 and 16 hours, a conclusion can be made that 8 hours was the most significant 
level in respect to time. A significant interaction was seen at 8 hours 100-200rpm and 16 hours 100-
200rpm p=0.003 and p=0.01 respectively.  
 
Table 2. The table below shows the most significant interactions seen from the interaction analysis 
using a two-way ANOVA. 
T4  Interaction  P value 
400rpm 28-37 oC 0.000123 
400rpm MOI 1-2.5 0.000072 
1 hour MOI 1-2.5 0.000003 
K 20 oC MOI 0.1-1 0.000079 
20 oC MOI 1-10 0.000155 
200rpm MOI 0.1-1 0.000443 
200rpm MOI 1-10 0.000443 
20 oC 150-200rpm 0.000157 
 
 
The phage K infection process shows far more interactions, between each factor/level used 
compared to the T4 phage interaction plot. Therefore, each factor and level contributed more to the 
phage K fermentation process than T4. However, it is known that factors can have different influences 
on different phage growth parameters (Bourdin et al, 2014).  Additionally, it was notable to see the 
effect that temperature had on both bioprocesses and the effect of agitation on the phage K bioprocess 
with agitation heavily contributed to the phage K titre but had a lesser effect on T4 titre. The results of 
the experimental design and the interaction analysis were validated by performing nine independent 
experiment runs of the conditions which gave the greatest titre for T4 phage (MOI 2.5, 225rpm, 28oC, 
3 hours infection). However, phage K used an MOI 0.1, 150rpm, 28oC, 4 hours infection as a similar 
titre was achieved when compared to MOI 1, 150rpm, 28oC, 8 hours infection, 3.5x1012 ± 5x1011 and 
6.5x1012 ± 5x1011 respectively. 
From the nine validation runs T4 phage gave an average harvest titre of 1.87 x 1013 ± 8.47 x 
1012 pfu/ml and phage K gave an average harvest titre of 2.41 x 1012 ± 7.63 x 1011 pfu/ml, with no 
statistical significant difference between any of the validation runs nor the initial experimental scaled 
down run. A 45% and 55% variation was seen within the phage K and T4 phage validation runs 
respectively.  Due to a lack of distinct peaks in the contour plots, validation of the greatest titre 
conditions  shows  they can consistently achieve high phage titres in a reliable manner.  
Infection temperature investigation 
The results of the interaction analysis showed the temperature during infection was the input 
variable with greatest influence on output phage titre. To validate this a further study was conducted 
where infection temperature was altered whilst all other input variables remained constant at the 
levels determined by the scaled down experiment for maximal output phage titre, T4 phage (MOI 2.5, 
225rpm, 3 hours) phage K (MOI 0.1, 150rpm, 4 hours). The experiments were carried out in triplicate 
with each experiment enumerated with triplicate plaque assays. Additionally, to examine the 
bioprocesses against each other, normalised values of process output per process input were 
calculated, these were the phage output per input host cell (host cell number determined at the point of 
infection) and the phage output per input phage (input phage determined at the point of infection for 
MOI).  
 
 
Figure 3. Effects of infection temperature on bacteriophage bioprocess outputs. A range of 
infection temperatures were investigated (shown on the x-axis for all graphs, A-F) whilst maintaining 
other input varaibles at previously validated levels for maximal output phage titre. The levels for T4 
phage were MOI 2.5, 225rpm agitation and 3 hours infection time. The levels for phage K were MOI 
0.1, 150rpm agitation and 4 hours infection time. The experiments were carried out in triplicate and 
enumerated with triplicate plaque assays. Graphs A-C show T4 phage process outputs, graphs D-F 
show phage K process outputs. Column 1 (Graphs A and D) shows output phage titre (PFU/ml), 
column 2 (Graphs B and E) shows normalised data of number of output phage per number of input 
host cells (at the point of infection), and column 3 (Graphs C and F) shows normalised data of number 
of output phage per number of input phage (at the point of infection). 
Overall Figure 3 clearly shows a distinct peak of productivity related to infection temperature 
for both bacteriophage bioprocesses. For the T4 process, the peak sits clearly at 28ºC across all graphs 
(A-C) with maximal output titre of 2.2x1013 ± 1.2x1012 pfu/ml. By normalising the data to show 
output yield vs. input host cells or input phage at the point of infection the improvement to the 
bioprocess output is more clearly observed. Only the bioprocess with a temperature of infection at 
28ºC produced ≥100,000 output phage per single input phage, whereas the bioprocesses with a 
temperature of infection at either 20ºC or 37ºC were producing <1,000 output phage per single input 
phage, p<0.0001. As Greico et al (2012) found only a 10 fold increase in their data, by examining 
more variables our bioprocess has been able to show almost a 3 order of magnitude increase in T4 
phage titre. For the phage K process, there is a window of operation for infection temperature where 
the greatest output phage titres can be achieved, ranging from 26-31oC. This result was not 
unexpected as the contour plot analysis illustrated a wider range of infection temperatures where 
similarly high output phage titres were achieved in the scaled down model for phage K; this is in 
contrast to the more defined design space that was achieved for T4. The contour plot analysis 
predicted infection temperatures between 23-34oC could achieve >1x 1012 pfu/ml for phage K, this 
analysis combined with the scaled down experiment and interaction analyses enabled selection of 
infection temperature as the input variable with greatest influence on output phage titre. This closer 
investigation of the infection temperature, after honing in and validating the levels of the other input 
variables, has demonstrated that titres >1x 1012 pfu/ml can only be achieved between 26-31oC (Figure 
3, Graph D). Normalised data show that it is only within this infection temperature range that 
bioprocess productivity achieves levels exceeding 10,000 output phage per single input host cell and 
exceeding 100,000 output phage per single input phage. Further gains in the output phage per input 
phage were seen due to the fact that a lower MOI was selected from the scaled down experiment 
(from 1 to 0.1). The phage K bioprocesses with lower temperature of infection at either 20ºC or 37ºC 
were producing <1000 output phage per single input cell or <10,000 output phage per single input 
phage, in a similar trend to that observed for T4. Statistically significant differences were observed 
between 28ºC and 20/37ºC between the phage output per input cell p<0.0001 for both temperatures 
and phage output per input phage between 28ºC and 20/37ºC, p<0.0001 for both temperatures.  
The improvement in phage titre, at a reduced temperature of infection to 28ºC was also 
observed by Greico et al. (2012). Their study showed  a 10-fold increase in phage titre could be 
achieved, when filamentous phage was infected at 28oC, compared to their best process at 37oC, 
however, this is the first study to throughly examine the effect of temperature of infection on phage 
titre (Greico et al, 2012). Hadas et al (1997) previously hypothesised that by preventing cell 
replication, at a lower temperature of infection, the host cells become larger and therefore have more 
available binding sites for phage. Additionally, Bleckwenn et al (2005) suggested that a temperature 
reduction may aid in viral protein synthesis and further exploratory work here would be beneficial. 
Our results show that there is a significant increase in productivity in bacteriophage bioprocessing in 
relation to the temperature during infection and future work intends to investigate the underpinning 
biological mechansims for this increase.  
Although currently, the gold standard method for phage enumeration is through the plaque 
assay, normalising the data to phage output per input host cell and phage output per input phage can 
offer greater insight into the success of the bioprocess. Simply looking at the pfu/ml, does not  take 
into account the MOI which can be highly variable in the literature, with MOI values commonly used 
anywhere between 1 – 10 (Bourdin et al 2014, Bryan et al 2016). Whilst these measurements are not 
widely found within the phage literature, they allow a universal method of enumeration to be used 
which takes into account the input variables (MOI) whilst also examining the final phage output. Fold 
expansion and population doubling are used within mammalian cell research and allow authors to 
easily cross compare their data to others. With phage fermentation research increasing cross 
comparision this will become more important and phage fermentation research may benefit from a 
similar method (Kumar et al, 2015, Sanz-Ruiz et al, 2017, González-Menéndez et al, 2018) 
Infection kinetics: adsorption and burst size analysis 
 In order to investigate why the combined input variable analysis led to improved output phage 
titre an analysis of the kinetics of infection such as phage adsorption and burst size was conducted. 
The burst size is the number of phage produced per infected host cell and shows the increase in phage 
titre after a single infection cycle (Golec et al, 2014). Earlier adsorption may be occurring with the 
improved conditions thereby speeding up the infection process and leading to larger burst size upon 
the first infection cycle. Therefore, the rate of adsorption was determined by examining the number of 
free phage available every 30 seconds in the culture after the infection (from the point of infection 
until 5 minutes post-infection). The T4 phage adsorption for the baseline (control) and greatest titre 
conditions are shown in Figure 4. A statistically significant reduction  in the number of free phage 
was observed at all time points for both T4 and phage K when compared to the  baseline process. 
Therefore showing that by altering the key process input variable parameters, a significant 
improvement in phage adsorption to host cells can be achieved that contributes to an improved output 
phage titre. Following this, a statistically significant increase in burst size was also observed for both 
T4 and phage K when compared to the baseline conditions (Figure 4). There was an average burst size  
increase of 30% for T4 (p=0.03) and 56% for phage K (p=0.014). 
     
 Figure 4. Infection kinetics. The graph shows an analysis in the scaled down model of the adsorption 
and burst size between the baseline (control) conditions and the full factorial design determined 
improved input variable conditions. Graphs A and B show the adsorption charts for T4 and phage K 
with baseline (control) conditions (red squares) and improved output phage titre condition (blue 
diamonds), depicting the reducing number of free phage available over time after infection. Graphs C 
and D show increased burst size (the number of phage produced per infected host cell after a single 
infection cycle) with improved conditions Each experiment was carried out in quadruplicate with 
individual experiments enumerated by duplicate plaque assays. 
  
Although multiple factors can affect phage adsorption, in this study the temperature of 
infection significantly improved the adsorption of the phage to its host organism and burst size 
observed  between the conditions, indicating that  when infection occurs earlier more phage can be 
produced in a shorter time period. Previous studies have shown that over wider ranges of 
temperatures, the rate of phage adsorption can be significantly affected (Quiberoni et al, 1998, 
Moldovan et al, 2007). Whilst Greico et al (2012) were able to show an improvement in phage titre at 
reduced temperature, they were unable to offer an explanation for the improvement in phage titre as 
infection kinetics analysis was not performed but stated a consideration should be given to the host 
growth whilst Brown and Bidle (2014) recognised it as a key parameter for viral infection. Wechuck 
et al (2002) showed that viruses are more stable at lower temperatures and when used as vectors can 
improve yield at lower temperatures.  The authors  hypothesied that with a lower temperature of 
infection, the phage DNA may be able to integrate more efficiently and therefore lead to a higher 
phage yield and therefore cause a bigger burst. Additionally, lowering the temperature of infection 
may prevent optimal growth of the host and keep the density lower which will be more favourable to 
phage propagation. Future exploratory work would therefore be hugely advantageous. One study 
showed that reducing the temperature of infection could upregulate the gene responsible for phage 
binding and therefore, more phage would be able to infect the host thus producing more phage and 
may represent an interesting avenue to explore (Tokman et al, 2016). 
 Whilst the study thus far demonstrated how manipulation of the conditions that contribute to 
phage infection can significantly improve bioprocess yields and generally improve phage propagation 
in a streamlined and efficient manner, it was important to translate the bioprocess to a manufacturing 
scale using a stirred tank bioreactor system. To date, there have been a minimal number of studies 
examining phage culture in stirred tank systems, however, this is the next logical step in 
bacteriophage manufacture (Agboluaje & Sauvageau, 2017, Krysiak et al, 2018))  
 
Scale up 
The translation of shake flask culture to stirred tank bioreactor is not straightforward as there 
are differences in oxygen transfer rates and mixing due to differences in fluid mechanics, heat transfer 
and agitation which can alter the bioprocess outputs. To determine whether the effects observed in the 
20ml volume shake flask scaled down model were transferable to industrial bioprocessing equipment, 
the conditions which gave the greatest phage titres were applied in a 3L working volume within a 5L 
automatically controlled stirred tank bioreactor. To date, a limited body of work exists that examines 
large scale stirred tank bioreactors for bacteriophage production. However, this translation is welcome 
as more automated control of cultures and parameter analytics in industrial bioreactors will enable 
reductions in operator and batch-to-batch related variation. Figure 5 shows the baseline and greatest 
titre conditions scale up from the scaled down shake flask model (20ml) to 5L bioreactor (3L working 
volume) for both T4 phage and phage K bioprocesses.  
 
 
 
 
 
 
 
 
 
 
 
 Figure 5. Culture System Output Comparison. The graphs show a comparison of output 
phage titres between the scaled down culture system (working volume 20ml) and the 5L bioreactor 
system (working volume 3L). Figure 5A shows the outputs for the T4 phage bioprocess and Graph B 
shows the phage K bioprocess outputs. Each graph shows a comparison between the baseline phage 
process parameters (black bars) and the process parameters that provided significantly improved 
output phage titres (grey bars) from the scaled down model and the translation to the 5L bioreactor. 
No statistically significant difference was found between either of the baseline or greatest titre 
conditions between culture systems for T4 phage using a paired t-test. Each experiment was 
performed in triplicate with individual experiments enumerated by triplicate plaque assays (bars 
represent average output titre, error bars represent 1 standard deviation)   
  
The trend of significantly improved output phage titre observed in the scaled down model 
when compared to the baseline input variable conditions was also observed in the 5L bioreactor for 
both bioprocesses, thereby confirming that changes in the scaled down model were translated to an 
industrial scale system.  Importantly, within the two culture systems for both phage bioprocesses, 
there was no statistically significant difference in output phage titre for the greatest titre conditions in 
20ml volume or 3L volume, demonstrating that the scaled down model provides a robust starting 
point for effective process scaling. A significant difference, p<0.0001, was found for phage K 
between the baseline conditions in the two culture systems with the shake flask giving a higher titre. 
This result shows the potential issues with scaling up a bioprocess and if a similar result has been 
found for the greatest titre conditions, for either phage, further investigations would be needed.  
This is the first study to examine phage yield in a shake flask system and translate the process 
into a stirred tank bioreactor system. Developing the scaled down model was of critical importance as 
variable shake flask processes often lead to difficulties in achieving similar yields when the process is 
moved on into a stirred tank system (Mitchell et al, 2000, Garcia-Ochoa & Gomez 2009, Tikhomirova 
et al, 2018). The research presented here has shown that by narrowing the conditions used and 
focussing on those that positively influence phage infection, the titre achieved is reliable and validated 
at small scale and in a scale up system which focuses on larger volumes, automation, and controllable 
parameters i.e pH and DO2. Previous studies have shown a greater variance in titre achieved 
compared to our work as no optimisation of the bioprocess was performed (Bourdin et al., 2014, 
Sauvageau & Cooper, 2010). Improving the phage bioprocess in shake flasks allows more rapid 
experiments to be completed which can then be moved into a stirred tank system. However, further 
work will investigate differences between optimising for batch bioprocessing and continuous 
bioprocessing, as well as to investigate the key process inputs and outputs of large scale phage 
bioprocessing with a view towards maximising the achievable process outputs in a reliable and robust 
manner. 
Conclusion 
This study examined the T4 phage and phage K bioprocess using a full factorial design in 
shake flasks. KPIV were used at a variety of levels to determine their effect on the phage titre. 
Interestingly, the temperature of infection was shown to have a significant effect on both of the phage 
titres, whilst the interaction analysis showed the effect of agitation on the phage K bioprocess. This 
was an interesting result as the phage effect on temperature is something that has been understudied, 
therefore, this paper explored the temperature of infection within a 4oC range and found nearly an 
order of magnitude difference between each temperature used. Additionally, the T4 phage bioprocess 
showed a peak in the phage titre compared to the phage K which showed that there was a window of 
infection where the greatest titres could be achieved. The curve showed a peak at 28oC which again 
was consistent with the scaled down experiment for T4 whereas phage K showed a window between 
26-31oC. The importance of phage output per input cell/phage was also highlighted and may give a 
more accurate representation of the bioprocess, by taking into account the MOI. Future phage 
fermentation studies should focus more heavily on the number of phage per input phage as this gives a 
more clear understanding of the bioprocess rather than the currently used pfu/ml. Additionally, an 
investigation into the mechanism of temperature reduction on phage titre improvement would be 
worthwhile. Examining the cost per phage and phage produced per minute/hour may also be 
beneficial and gain a further insight into the bioprocess whilst further experiments in the stirred tank 
bioreactor would be beneficial in order to try and further improve upon the bioprocess. 
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